Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DHR vs GSK✓SelectedUSD · GSKDHR vs GSK performance historyLatest closeAs of-1.80%11/17
Stock and ETF performance explorer

DHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59,795.8%
GSK return
+1,698.4%
Excess return
+58,097.5%
Maximum drawdown
-45.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-2.3%+0.5%-1.1%
7D-4.4%-3.0%-1.4%-3.5%
30D-1.4%+0.4%-1.8%-1.7%
3M+11.6%-1.2%+12.8%+11.8%
6M+40.0%+0.9%+39.0%+39.0%
YTD-0.8%+4.0%-4.8%-2.8%
1Y+3.2%+7.3%-4.1%+0.1%
3Y+10.6%+57.1%-46.5%-5.9%
5Y-15.6%+43.0%-58.6%-26.8%
10Y+235.2%+103.1%+132.1%+159.2%
All+59,795.8%+1,698.4%+58,097.5%+25,050.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling